China’s Cell and Gene Therapy (CGT) industry continued its rapid expansion in the first quarter of 2026, remaining one of the most attractive sectors for biotech investment.According to publicly disc...
May 2026 - Andelyn Biosciences has launched a new standardized lentiviral vector manufacturing solution designed to support scalable cell therapy development and commercialization.The newly introduced...
May 2026 - Cellares has announced the European launch of its automated Cell Shuttle™ manufacturing platform, marking another step toward large-scale industrialization of cell therapy production. Acco...
May 2026 - The global biopharmaceutical industry is witnessing a renewed wave of merger and acquisition activity as leading pharmaceutical companies respond to increasing pressure from upcoming patent...
May 2026 - The cell therapy industry is entering a new phase of commercialization as companies increasingly focus on scalable and automated manufacturing infrastructure. This week, Cabaletta Bio and C...
On April 21, a South Korean business delegation visited Wuzhong District, where the Wuzhong District People’s Government and the Korea Bio-Pharma Association jointly organized a China-South Korea Bus...
April 2026 - Eli Lilly and Company has announced plans to acquire biotechnology firm Kelonia Therapeutics in a deal valued at up to $7 billion, highlighting the growing strategic importance of next-ge...
April 2026 - Researchers are continuing to uncover new biological targets that could expand the potential of engineered immune cell therapies. Recently, Precision Biologics reported the identification...
April 2026 - Researchers and biotechnology companies continue to expand the potential of natural killer (NK) cell therapies as new targets and engineering strategies emerge. Recently, Precision Biolog...
April 2026 - The clinical development of CAR-NK cell therapies may be entering a new phase as treatment logistics become simpler and more accessible. Recently, Nkarta announced that it has reached an ...
April 2026 - Recent policy discussions in the United States are raising new questions for the global biopharmaceutical industry. The administration of Donald Trump is reportedly considering tariffs on...
April 2026 - Recent advances in NK cell manufacturing are drawing renewed attention to one of the most critical challenges in cell therapy development: scalable and efficient cell expansion. A newly r...
86 198 5711 6962 
info@hillgene.com 
English
